BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

341 related articles for article (PubMed ID: 25804679)

  • 1. Serum Phosphorus and Progression of CKD and Mortality: A Meta-analysis of Cohort Studies.
    Da J; Xie X; Wolf M; Disthabanchong S; Wang J; Zha Y; Lv J; Zhang L; Wang H
    Am J Kidney Dis; 2015 Aug; 66(2):258-65. PubMed ID: 25804679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of Drug Effects on Serum Parathyroid Hormone, Phosphorus, and Calcium Levels With Mortality in CKD: A Meta-analysis.
    Palmer SC; Teixeira-Pinto A; Saglimbene V; Craig JC; Macaskill P; Tonelli M; de Berardis G; Ruospo M; Strippoli GF
    Am J Kidney Dis; 2015 Dec; 66(6):962-71. PubMed ID: 26003472
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benefits and harms of phosphate binders in CKD: a systematic review of randomized controlled trials.
    Navaneethan SD; Palmer SC; Craig JC; Elder GJ; Strippoli GF
    Am J Kidney Dis; 2009 Oct; 54(4):619-37. PubMed ID: 19692157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcomes associated with serum phosphorus level in males with non-dialysis dependent chronic kidney disease.
    Kovesdy CP; Anderson JE; Kalantar-Zadeh K
    Clin Nephrol; 2010 Apr; 73(4):268-75. PubMed ID: 20353734
    [TBL] [Abstract][Full Text] [Related]  

  • 5. No independent association of serum phosphorus with risk for death or progression to end-stage renal disease in a large screen for chronic kidney disease.
    Mehrotra R; Peralta CA; Chen SC; Li S; Sachs M; Shah A; Norris K; Saab G; Whaley-Connell A; Kestenbaum B; McCullough PA;
    Kidney Int; 2013 Nov; 84(5):989-97. PubMed ID: 23615501
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum Phosphorus and Risk of Cardiovascular Disease, All-Cause Mortality, or Graft Failure in Kidney Transplant Recipients: An Ancillary Study of the FAVORIT Trial Cohort.
    Merhi B; Shireman T; Carpenter MA; Kusek JW; Jacques P; Pfeffer M; Rao M; Foster MC; Kim SJ; Pesavento TE; Smith SR; Kew CE; House AA; Gohh R; Weiner DE; Levey AS; Ix JH; Bostom A
    Am J Kidney Dis; 2017 Sep; 70(3):377-385. PubMed ID: 28579423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GFR at initiation of dialysis and mortality in CKD: a meta-analysis.
    Susantitaphong P; Altamimi S; Ashkar M; Balk EM; Stel VS; Wright S; Jaber BL
    Am J Kidney Dis; 2012 Jun; 59(6):829-40. PubMed ID: 22465328
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circulating α-klotho levels in CKD and relationship to progression.
    Kim HR; Nam BY; Kim DW; Kang MW; Han JH; Lee MJ; Shin DH; Doh FM; Koo HM; Ko KI; Kim CH; Oh HJ; Yoo TH; Kang SW; Han DS; Han SH
    Am J Kidney Dis; 2013 Jun; 61(6):899-909. PubMed ID: 23540260
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Serum Ig Free Light Chains with Mortality and ESRD among Patients with Nondialysis-Dependent CKD.
    Ritchie J; Assi LK; Burmeister A; Hoefield R; Cockwell P; Kalra PA
    Clin J Am Soc Nephrol; 2015 May; 10(5):740-9. PubMed ID: 25825483
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum magnesium, mortality, and cardiovascular disease in chronic kidney disease and end-stage renal disease patients: a systematic review and meta-analysis.
    Xiong J; He T; Wang M; Nie L; Zhang Y; Wang Y; Huang Y; Feng B; Zhang J; Zhao J
    J Nephrol; 2019 Oct; 32(5):791-802. PubMed ID: 30888644
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic importance of serum alkaline phosphatase in CKD stages 3-4 in a clinical population.
    Taliercio JJ; Schold JD; Simon JF; Arrigain S; Tang A; Saab G; Nally JV; Navaneethan SD
    Am J Kidney Dis; 2013 Oct; 62(4):703-10. PubMed ID: 23769134
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of diet protein restriction on progression of chronic kidney disease: A systematic review and meta-analysis.
    Yan B; Su X; Xu B; Qiao X; Wang L
    PLoS One; 2018; 13(11):e0206134. PubMed ID: 30403710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimated GFR Trajectories of People Entering CKD Stage 4 and Subsequent Kidney Disease Outcomes and Mortality.
    Xie Y; Bowe B; Xian H; Balasubramanian S; Al-Aly Z
    Am J Kidney Dis; 2016 Aug; 68(2):219-228. PubMed ID: 26948835
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Serum levels of phosphorus, parathyroid hormone, and calcium and risks of death and cardiovascular disease in individuals with chronic kidney disease: a systematic review and meta-analysis.
    Palmer SC; Hayen A; Macaskill P; Pellegrini F; Craig JC; Elder GJ; Strippoli GF
    JAMA; 2011 Mar; 305(11):1119-27. PubMed ID: 21406649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of soy protein containing isoflavones in patients with chronic kidney disease: A systematic review and meta-analysis.
    Jing Z; Wei-Jie Y
    Clin Nutr; 2016 Feb; 35(1):117-124. PubMed ID: 25882339
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PTH levels and not serum phosphorus levels are a predictor of the progression of kidney disease in elderly patients with advanced chronic kidney disease.
    Toapanta Gaibor NG; Nava Pérez NC; Martínez Echevers Y; Montes Delgado R; Guerrero Riscos MÁ
    Nefrologia; 2017; 37(2):149-157. PubMed ID: 27823902
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Associations of Soluble CD14 and Endotoxin with Mortality, Cardiovascular Disease, and Progression of Kidney Disease among Patients with CKD.
    Poesen R; Ramezani A; Claes K; Augustijns P; Kuypers D; Barrows IR; Muralidharan J; Evenepoel P; Meijers B; Raj DS
    Clin J Am Soc Nephrol; 2015 Sep; 10(9):1525-33. PubMed ID: 26153127
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association between Serum Inorganic Phosphorus Levels and Adverse Outcomes in Chronic Kidney Disease: The Fukushima CKD Cohort Study.
    Oda A; Tanaka K; Saito H; Iwasaki T; Watanabe S; Kimura H; Kazama S; Shimabukuro M; Asahi K; Watanabe T; Kazama JJ
    Intern Med; 2022 Jun; 61(11):1653-1662. PubMed ID: 34803092
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association between plasma phosphorus and renal outcome: A prospective cohort of patients majorly with glomerulonephritis.
    Xu D; Lv J; Wang J; Zhang L; Zhang H
    Nephrology (Carlton); 2017 Jan; 22(1):43-48. PubMed ID: 26769231
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression and outcomes of non-dialysis dependent chronic kidney disease patients: A single center longitudinal follow-up study.
    Khan YH; Sarriff A; Adnan AS; Khan AH; Mallhi TH; Jummaat F
    Nephrology (Carlton); 2017 Jan; 22(1):25-34. PubMed ID: 26718476
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.